ENDOCRINE 期刊简介
Well-established as a major journal in today’s rapidly advancing experimental and clinical research areas, Endocrine publishes original articles devoted to basic (including molecular, cellular and physiological studies), translational and clinical research in all the different fields of endocrinology and metabolism. Articles will be accepted based on peer-reviews, priority, and editorial decision. Invited reviews, mini-reviews and viewpoints on relevant pathophysiological and clinical topics, as well as Editorials on articles appearing in the Journal, are published. Unsolicited Editorials will be evaluated by the editorial team. Outcomes of scientific meetings, as well as guidelines and position statements, may be submitted. The Journal also considers special feature articles in the field of endocrine genetics and epigenetics, as well as articles devoted to novel methods and techniques in endocrinology.
Endocrine covers controversial, clinical endocrine issues. Meta-analyses on endocrine and metabolic topics are also accepted. Descriptions of single clinical cases and/or small patients studies are not published unless of exceptional interest. However, reports of novel imaging studies and endocrine side effects in single patients may be considered. Research letters and letters to the editor related or unrelated to recently published articles can be submitted.
Endocrine covers leading topics in endocrinology such as neuroendocrinology, pituitary and hypothalamic peptides, thyroid physiological and clinical aspects, bone and mineral metabolism and osteoporosis, obesity, lipid and energy metabolism and food intake control, insulin, Type 1 and Type 2 diabetes, hormones of male and female reproduction, adrenal diseases pediatric and geriatric endocrinology, endocrine hypertension and endocrine oncology.
作为当今快速发展的实验和临床研究领域的主要期刊,内分泌发表了专门针对内分泌学和代谢的所有不同领域的基础 (包括分子,细胞和生理研究),转化和临床研究的原始文章。文章将根据同行评审、优先级和编辑决定被接受。发表了有关病理生理和临床主题的邀请评论,小型评论和观点,以及有关该杂志上发表的文章的社论。未经请求的社论将由编辑团队进行评估。可以提交科学会议的成果以及准则和立场声明。该杂志还考虑了内分泌遗传学和表观遗传学领域的专题文章,以及致力于内分泌学新方法和技术的文章。
内分泌涵盖有争议的临床内分泌问题。关于内分泌和代谢主题的荟萃分析也被接受。除非特别感兴趣,否则不会发表单个临床病例和/或小型患者研究的描述。但是,可以考虑在单个患者中进行新的影像学研究和内分泌副作用的报道。可以提交与最近发表的文章相关或无关的研究书和给编辑的信。
内分泌涵盖了内分泌学的主要主题,例如神经内分泌学,垂体和下丘脑肽,甲状腺生理和临床方面,骨骼和矿物质代谢以及骨质疏松症,肥胖症,脂质和能量代谢与食物摄入控制,胰岛素,1型和2型糖尿病,男性和女性生殖激素,小儿和老年内分泌疾病,内分泌高血压和内分泌肿瘤学。
期刊ISSN
|
1355-008X |
影响指数
|
3.597 |
最新CiteScore值
|
5.80 查看CiteScore评价数据 |
最新自引率
|
4.90% |
官方指定润色网址
|
https://www.deeredit.com/?type=ss1 |
投稿语言要求
|
Improve the quality of the paper, eliminate grammar and spelling errors, increase readability, ensure accurate communication of viewpoints, enhance academic reputation, and increase the chances of the paper being accepted. 建议点击这个网址:https://www.deeredit.com/?type=ss2,资深审稿专家为您评估稿件质量,提供针对性改进建议,最终可助您极大提升目标期刊录用率 |
期刊官方网址
hot |
https://www.peipusci.com/?type=9 |
杂志社征稿网址
hot |
https://www.peipusci.com/?type=10 |
通讯地址
|
ONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, United States, NY, 10004 |
偏重的研究方向(学科)
|
ENDOCRINOLOGY & METABOLISM- |
出版周期
|
|
出版年份
|
1995 |
出版国家/地区
|
UNITED STATES |
是否OA
|
No |
SCI期刊coverage
|
Science Citation Index Expanded(科学引文索引扩展) |
NCBI查询
|
PubMed Central (PMC)链接 全文检索(pubmed central) |
最新中科院JCR分区
|
大类(学科)
小类(学科)
综述期刊
医学
ENDOCRINOLOGY & METABOLISM(内分泌学与代谢)3区
否
|
|||||
最新的影响因子
|
3.597 | |||||
最新公布的期刊年发文量 |
|
|||||
总被引频次 | 74 | |||||
影响因子趋势图 |
近年的影响因子趋势图(整体平稳趋势)
|
2022年预警名单预测最新
最新CiteScore值
|
5.80
|
||||||||||||||
年文章数 | 405 | ||||||||||||||
SJR
|
1.002 | ||||||||||||||
SNIP
|
1.232 | ||||||||||||||
CiteScore排名
|
|
||||||||||||||
CiteScore趋势图 |
CiteScore趋势图
|
本刊同领域相关期刊
|
|
期刊名称 | IF值 |
DOMESTIC ANIMAL ENDOCRINOLOGY | 2.267 |
BONE | 4.354 |
THYROID | 6.502 |
DIABETES | 9.366 |
Pituitary | 4.066 |
ENDOCRINE | 3.597 |
Diabetologe | 0.394 |
DIABETOLOGIA | 10.021 |
Metabolomics | 4.247 |
本刊同分区等级的相关期刊
|
|
期刊名称 | IF值 |
DOMESTIC ANIMAL ENDOCRINOLOGY | 2.267 |
Pituitary | 4.066 |
ENDOCRINE | 3.597 |
Metabolomics | 4.247 |
Diabetes Therapy | 2.916 |
DIABETIC MEDICINE | 4.315 |
ACTA DIABETOLOGICA | 4.237 |
Journal of Diabetes | 3.966 |
Endocrine Connections | 3.302 |
分享者 | 点评内容 |